MEM vs RGT

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

MEM

MEMPHASYS FPO [MEM]

44LOW

RGT

ARGENTBIO FPO [RGT]

44LOW

Score Breakdown

MEM RGT
Technical
50
61
Catalyst
55
51
Sentiment
50
50
Fundamental
22
34
Momentum
61
50
Risk Gate
31
37

Key Metrics

MEM Metric RGT
$24.7MMarket Cap$6.9M
7.0MAvg Volume (20d)1.2M
N/AShort InterestN/A
$0.00952-Week High$0.320
$0.00352-Week Low$0.033
-12.5%Daily Change-1.7%
$0.007Entry Price$0.058
-87.4%ROEN/A
N/AProfit MarginN/A

Active Signals

MEM Signals

●MACD crossed bearish — momentum is fading
●Beating the Small Ords index — relative strength of 1.25, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.6 quarters)
●Very high P/S ratio (115.4x)
●Revenue in sharp decline (-96%)
●Piotroski F-Score weak (2/9, low-confidence approx)
●Near 52-week high (91% of range)

RGT Signals

●Trading above both moving averages — the trend is your friend here
●Volume surging at 13.2x normal while price climbs — real buying conviction behind this move
●Took a hit — down 14.7% over the last 5 days
●Beating the Small Ords index — relative strength of 1.68, so it's outpacing the pack
●Volatility is expanding fast — choppy price action, so buckle up
●Trading above the 200-day average — the long-term trend is on your side
●Critical cash runway (0.8 quarters)
●Strong revenue growth (+3905%)

Ask Scout AI to compare MEM and RGT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MEM Full Analysis → RGT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).